These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 22961001)

  • 41. Chromosomal instability in Barrett's esophagus is related to telomere shortening.
    Finley JC; Reid BJ; Odze RD; Sanchez CA; Galipeau P; Li X; Self SG; Gollahon KA; Blount PL; Rabinovitch PS
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1451-7. PubMed ID: 16896031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Barrett's esophagus and medications that relax the lower esophageal sphincter.
    Corley DA; Levin TR; Habel LA; Buffler PA
    Am J Gastroenterol; 2006 May; 101(5):937-44. PubMed ID: 16573773
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adiponectin May Modify the Risk of Barrett's Esophagus in Patients With Gastroesophageal Reflux Disease.
    Almers LM; Graham JE; Havel PJ; Corley DA
    Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2256-64.e1-3. PubMed ID: 25632808
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of Barrett's esophagus in relatives by endoscopic screening.
    Chak A; Faulx A; Kinnard M; Brock W; Willis J; Wiesner GL; Parrado AR; Goddard KA
    Am J Gastroenterol; 2004 Nov; 99(11):2107-14. PubMed ID: 15554988
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
    Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
    Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prioritization and functional analysis of GWAS risk loci for Barrett's esophagus and esophageal adenocarcinoma.
    Chen J; Ali MW; Yan L; Dighe SG; Dai JY; Vaughan TL; Casey G; Buas MF
    Hum Mol Genet; 2022 Feb; 31(3):410-422. PubMed ID: 34505128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas.
    Corley DA; Mehtani K; Quesenberry C; Zhao W; de Boer J; Weiss NS
    Gastroenterology; 2013 Aug; 145(2):312-9.e1. PubMed ID: 23673354
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic Obstructive Pulmonary Disease and the Risk of Esophagitis, Barrett's Esophagus, and Esophageal Adenocarcinoma: A Primary Care Case-Control Study.
    Menon S; Nightingale P; Trudgill N
    J Clin Gastroenterol; 2019; 53(10):e451-e455. PubMed ID: 31008868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Myo9B is associated with an increased risk of Barrett's esophagus and esophageal adenocarcinoma.
    Menke V; Van Zoest KP; Moons LM; Pot RG; Siersema PD; Kuipers EJ; Kusters JG
    Scand J Gastroenterol; 2012 Dec; 47(12):1422-8. PubMed ID: 22954106
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Barrett's esophagus: prevalence in symptomatic relatives.
    Romero Y; Cameron AJ; Schaid DJ; McDonnell SK; Burgart LJ; Hardtke CL; Murray JA; Locke GR
    Am J Gastroenterol; 2002 May; 97(5):1127-32. PubMed ID: 12017151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gastric surgery is not a risk for Barrett's esophagus or esophageal adenocarcinoma.
    Avidan B; Sonnenberg A; Schnell TG; Sontag SJ
    Gastroenterology; 2001 Dec; 121(6):1281-5. PubMed ID: 11729106
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus.
    Thrift AP; Anderson LA; Murray LJ; Cook MB; Shaheen NJ; Rubenstein JH; El-Serag HB; Vaughan TL; Schneider JL; Whiteman DC; Corley DA
    Am J Gastroenterol; 2016 Nov; 111(11):1528-1535. PubMed ID: 27575711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's Esophagus.
    Critchley-Thorne RJ; Davison JM; Prichard JW; Reese LM; Zhang Y; Repa K; Li J; Diehl DL; Jhala NC; Ginsberg GG; DeMarshall M; Foxwell T; Jobe BA; Zaidi AH; Duits LC; Bergman JJ; Rustgi A; Falk GW
    Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):240-248. PubMed ID: 27729357
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of Barrett's esophagus.
    Schneider JL; Zhao WK; Corley DA
    Dig Dis Sci; 2015 Feb; 60(2):436-43. PubMed ID: 25213077
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of methylenetetrahydrofolate reductase C677T-A1298C polymorphisms with risk for esophageal adenocarcinoma, Barrett's esophagus, and reflux esophagitis.
    Ekiz F; Ormeci N; Coban S; Karabulut HG; Aktas B; Tukun A; Tuncali T; Yüksel O; Alkış N
    Dis Esophagus; 2012 Jul; 25(5):437-41. PubMed ID: 21951971
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genomic regions associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma in African Americans: The cross BETRNet admixture study.
    Sun X; Chandar AK; Canto MI; Thota PN; Brock M; Shaheen NJ; Beer DG; Wang JS; Falk GW; Iyer PG; Abrams JA; Venkat-Ramani M; Veigl M; Miron A; Willis J; Patil DT; Nalbantoglu I; Guda K; Markowitz SD; Zhu X; Elston R; Chak A
    PLoS One; 2017; 12(10):e0184962. PubMed ID: 29073141
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Barrett's esophagus: prevalence and size of hiatal hernia.
    Cameron AJ
    Am J Gastroenterol; 1999 Aug; 94(8):2054-9. PubMed ID: 10445527
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma.
    Brabender J; Marjoram P; Lord RV; Metzger R; Salonga D; Vallböhmer D; Schäfer H; Danenberg KD; Danenberg PV; Selaru FM; Baldus SE; Hölscher AH; Meltzer SJ; Schneider PM
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2113-7. PubMed ID: 16172218
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutagen sensitivity and neoplastic progression in patients with Barrett's esophagus: a prospective analysis.
    Chao DL; Maley CC; Wu X; Farrow DC; Galipeau PC; Sanchez CA; Paulson TG; Rabinovitch PS; Reid BJ; Spitz MR; Vaughan TL
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1935-40. PubMed ID: 17035402
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Abdominal obesity and body mass index as risk factors for Barrett's esophagus.
    Corley DA; Kubo A; Levin TR; Block G; Habel L; Zhao W; Leighton P; Quesenberry C; Rumore GJ; Buffler PA
    Gastroenterology; 2007 Jul; 133(1):34-41; quiz 311. PubMed ID: 17631128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.